Optometrists in South Carolina - Medicare Status, Address, Contact

1261 Optometrists found. Showing 241 - 260

Eye Care Specialties Group - James Island Optometrist Medicare: Not Enrolled in Medicare Practice Location: 776 Daniel Ellis Dr, Unit 3b, Charleston, SC 29412 Phone: 843-573-9944

Visionary Eye Center Optometrist Medicare: Medicare Enrolled Practice Location: 2015 Sam Rittenberg Blvd, Charleston, SC 29407 Phone: 843-763-2247

Eye On Eyes Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2070 Sam Rittenberg Blvd, Suite 412, Charleston, SC 29407 Phone: 843-556-8844    Fax: 843-556-9335

Dr. Richard Charles Bedell, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2070 Sam Rittenberg Blvd, Charleston, SC 29407 Phone: 843-810-0634

Dr. Abby J. Schmidt, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2070 Sam Rittenberg Blvd Ste 412, Charleston, SC 29407 Phone: 843-627-2020

Megan Walton, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2060 Charlie Hall Blvd Ste 201, Charleston, SC 29414 Phone: 843-722-2010    Fax: 843-723-3914

Dr. Jeremy David Walz, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414

Dr. Francis Weston Shealy Iii, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1251 Savannah Hwy, Charleston, SC 29407 Phone: 843-763-2270

Robert H Wilds, OD Optometrist Medicare: Medicare Enrolled Practice Location: 105 Wappoo Creek Drive, Suite 4b, Charleston, SC 29412 Phone: 843-795-7971

Dr. William Terry Allen, O.D. Optometrist - Corneal and Contact Management Medicare: Not Enrolled in Medicare Practice Location: 3951 W Ashley Cir, Charleston, SC 29414 Phone: 843-852-0075    Fax: 843-852-0600

Comprehensive Eyecare At West Ashley Llc Optometrist Medicare: Medicare Enrolled Practice Location: 3050 Ashley Town Center Dr, Charleston, SC 29414 Phone: 912-348-4584

Dr. Michael Wayne Zolman, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 325 Folly Rd, Suite 109, Charleston, SC 29412 Phone: 865-300-1670

See Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 355 King St, Charleston, SC 29401 Phone: 843-722-6101    Fax: 843-722-6103

Miss Sara Ashley Restuccio, OD Optometrist Medicare: Medicare Enrolled Practice Location: 109 Bee St, Charleston, SC 29401 Phone: 843-577-5011

Eye Care Specialties Group - West Ashley Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3531 Mary Ader Ave, Suite B, Charleston, SC 29414 Phone: 843-577-2047

Samantha Rieger-pinson, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 204 W Hill Blvd, Charleston Afb, SC 29404 Phone: 843-963-6855

Katie Creech Hickman, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 705 Chesterfield Hwy, Cheraw, SC 29520 Phone: 843-537-7711    Fax: 843-537-9582

Richard E Owens, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 705 Chesterfield Rd., Cheraw, SC 29520 Phone: 843-537-7711    Fax: 843-537-9582

Carolina Eye Associates Pa Optometrist Medicare: Medicare Enrolled Practice Location: 705 Chesterfield Hwy, Cheraw, SC 29520 Phone: 843-537-6962    Fax: 843-537-9582

Kay S. Bullard, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 703 Market St, Cheraw, SC 29520 Phone: 843-537-3641    Fax: 843-537-3646

News Archive

Study: REVLIMID and dexamethasone for high-risk smoldering multiple myeloma reduce risk of disease progression

Celgene International Sàrl (NASDAQ: CELG) announced that data evaluating combination therapy REVLIMID® (lenalidomide) and dexamethasone in patients with high-risk asymptomatic smoldering multiple myeloma were presented during the American Society of Hematology's annual meeting. The study reported REVLIMID and dexamethasone prolonged time to progression.

Positive results from sarilumab Phase 2b trial on RA, ankylosing spondylitis

Sanofi and Regeneron Pharmaceuticals, Inc. announced results from Phase 2b trials in rheumatoid arthritis (RA) and ankylosing spondylitis (AS) with sarilumab, a novel, high-affinity, subcutaneously administered, fully-human antibody targeting the interleukin-6 receptor.

Medicago receives contract from U.S. Army Research, Development and Engineering Command laboratory

Medicago Inc. (TSX-V: MDG), a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that it has been awarded a proof of concept contract by the U.S. Army Research, Development and Engineering Command laboratory specifically the Edgewood Chemical Biological Center ("ECBC") Research & Technology Directorate.

Majority of Canadians living with diabetes do not receive all clinical tests from health providers

While most Canadian adults living with diabetes get regular care, they are not always getting all of the clinically recommended tests they require to prevent health complications.

BioVentrix announces completion of enrollment in PliCath HF human clinical trial

BioVentrix, developer of the PliCath HF System, today announced the achievement of a significant milestone - completion of enrollment in its pilot human clinical trial. PliCath HF is a novel device which enables Epicardial Catheter-based Ventricular Restoration (ECVR).

Read more Medical News

› Verified 8 days ago

• «
• 8
• 9
• 10
• 11
• 12
• 13(current)
• 14
• 15
• 16
• 17
• 18
• »